IEEE Brain: Understanding Early Stage Investors

  • Share
Create Account or Sign In to post comments

Althea Stillman, Ph.D.
Associate Director, Life Sciences | IP Group Inc.
Althea is Associate Director for Life Sciences at IP Group, an intellectual
property commercialization company. She is part of the team that drives
the company’s efforts to identify and develop early-stage technologies in
the life sciences stemming from premier research institutions in North
America. Currently, Althea is the investment lead and Board Director for several start-ups across IP
Group’s research partner network. Althea has experience in technologies ranging across the
healthcare and biotech sectors, as well as an extensive research background in neuroscience,
genetics and molecular biology. Prior to joining IP Group in 2016, Althea worked for the Penn
Center for Innovation, at the University of Pennsylvania. She holds a Ph.D. in Genetics from Yale
University and a B.A. in Molecular Cell Biology from the University of California, Berkeley

Understanding  Early Stage Investors